A Phase 2/3 Study in Adult and Pediatric Participants With SCD

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of osivelotor.
Epistemonikos ID: c2df4603a5c02e59fcec348bfc32867e5700923c
First added on: May 13, 2024